Nolvadex 25
$50.00
Iron Ascension Nolvadex 25 (Tamoxifen Citrate) is a core selective estrogen receptor modulator (SERM) engineered for targeted estrogen receptor blockade and endocrine recovery. By competitively binding to estrogen receptors in mammary tissue and at the hypothalamic-pituitary level, it provides direct protection against gynecomastia while stimulating the release of gonadotropins to restore endogenous testosterone production.
Guaranteed safe checkout
Description
Description
Iron Ascension Nolvadex 25
Specifications & Composition
| Specification | Details |
|---|---|
| Active Compound | Tamoxifen Citrate |
| Concentration | 25 mg per tablet |
| Total Quantity | 60 tablets |
| Delivery System | Oral administration |
| Formulation Standard | Pharmaceutical grade (manufacturer claim; verification required) |
| Batch Testing | High-Performance Liquid Chromatography (HPLC) |
Key Performance Features
- Estrogen Receptor Modulation: Tamoxifen is a selective estrogen receptor modulator (SERM) that blocks estrogen’s effects in certain tissues, including breast tissue. It is used medically in specific breast cancer indications and may be prescribed for certain cases of gynecomastia.
- Hormonal Signaling: By reducing estrogen-mediated feedback at the hypothalamus and pituitary, tamoxifen may increase LH and FSH signaling in some individuals.
- Post-Cycle Considerations: Tamoxifen has clinical applications in selected endocrine conditions, but it is not a guaranteed method of restoring hormonal function after anabolic steroid use or preserving lean muscle mass.
Important Health Considerations: Tamoxifen carries risks including blood clots, stroke, changes in vision, and liver-related adverse effects. It may also interact with other medications. Medical supervision is important.
Quality Control & Lab Verification
The manufacturer reports that each batch undergoes quantitative testing before allocation.
| Quality Control Parameter | Reported Result |
|---|---|
| Compound | Tamoxifen Citrate (oral tablets) |
| Assay Result | 99.7% active compound (reported) |
| Testing Method | HPLC (reported) |
| Verification Status | PASSED (reported; source also lists “HCG,” which requires clarification) |
Publication note: The 99.7% assay result, HPLC report, pharmaceutical-grade designation, and tablet formulation should be verified against a genuine, batch-specific certificate of analysis. The meaning of “HCG” in the supplied status line should be confirmed; it is not a substitute for a batch verification result. HPLC assay alone does not establish tablet uniformity, dissolution, contaminant absence, or product safety.
Specifications
- Short Stroke Gas Piston Gas System (Rifle Length)
- 18.6″ Barrel Length ( Mid-Weight style, non-fluted)
- 1:8 Twist Rate Rifling
Reviews
There are no reviews yet.